or Try an Advanced Search...

    Technical Analysis for RGT - Argent Biopharma Limited

    Grade Last Price % Change Price Change
    F 0.310 0.00% 0.000
    RGT closed unchanged on Friday, November 1, 2024, on 5 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong N/A Down Down
    Historical RGT trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Narrow Range Bar Range Contraction 3.33%
    Wide Bands Range Expansion 3.33%
    Oversold Stochastic Weakness 3.33%
    New Downtrend Bearish 3.33%
    Older End-of-Day Signals for RGT ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High 4 days ago
    Up 2% 4 days ago
    Up 1% 4 days ago
    Up 3% 4 days ago
    1.5x Volume Pace 4 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    RGT Chart by TradingView
    Basic chart:

    Profile

    Argent BioPharma Limited, a drug discovery clinical-stage biopharmaceutical company, provides medicines targeting immunology and neurology worldwide. Its principal product candidates include CimetrA, which is in phase II clinical trial for the treatment of SLE Lupus, anti-inflammatory, and SARS COVID-19; and CannEpil, which is in phase I clinical trial for refractory epilepsy and cerebral palsy; and CogniCann, which is in phase I clinical trial for the symptomatic relief of Dementia and Alzheimer. In addition, the company provides Irnican for brain cancer. The company was formerly known as MGC Pharmaceuticals Limited and changed it name to Argent BioPharma Limited. Argent BioPharma Limited was founded in 2014 and is based in Subiaco, Australia.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Biopharmaceutical Drug Discovery Dementia Brain Cancer Cerebral Palsy

    Is RGT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 16 Insider Spends AU$1.6m Buying More Shares In Argent BioPharma
    See more RGT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.57
    52 Week Low 0.15
    Average Volume 36,768
    200-Day Moving Average 0.000
    50-Day Moving Average 0.369
    20-Day Moving Average 0.406
    10-Day Moving Average 0.325
    Average True Range 0.032
    RSI (14) 40.12
    ADX 25.94
    +DI 24.945
    -DI 43.974
    Chandelier Exit (Long, 3 ATRs) 0.473
    Chandelier Exit (Short, 3 ATRs) 0.397
    Upper Bollinger Bands 0.596
    Lower Bollinger Band 0.216
    Percent B (%b) 0.25
    BandWidth 93.448
    MACD Line -0.026
    MACD Signal Line -0.010
    MACD Histogram -0.0157
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.310
    Resistance 3 (R3) 0.310 0.310 0.310
    Resistance 2 (R2) 0.310 0.310 0.310 0.310
    Resistance 1 (R1) 0.310 0.310 0.310 0.310 0.310
    Pivot Point 0.310 0.310 0.310 0.310 0.310
    Support 1 (S1) 0.310 0.310 0.310 0.310 0.310
    Support 2 (S2) 0.310 0.310 0.310 0.310
    Support 3 (S3) 0.310 0.310 0.310
    Support 4 (S4) 0.310